Filing Details

Accession Number:
0000914190-16-000864
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-10-31 17:10:01
Reporting Period:
2016-10-19
Filing Date:
2016-10-31
Accepted Time:
2016-10-31 17:10:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
842023 Bio-Techne Corp TECH Biological Products, (No Disgnostic Substances) (2836) 411427402
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
902080 C Roger Lucas 41 East Pleasant Lake Road
North Oaks MN 55127
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-10-19 100 $104.71 3,215 No 4 S Direct
Common Stock Acquisiton 2016-10-27 914 $0.00 4,129 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2016-10-27 3,985 $0.00 3,985 $101.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,985 2026-10-26 No 4 A Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Optoin (right to buy) $91.78 2014-10-30 2024-10-30 4,000 4,000 Direct
Common Stock Stock Option (right to buy) $87.39 2013-10-31 2023-10-30 4,000 4,000 Direct
Common Stock Stock Option (right to buy) $87.34 2016-10-29 2025-10-28 4,260 4,260 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-10-30 4,000 4,000 Direct
2023-10-30 4,000 4,000 Direct
2025-10-28 4,260 4,260 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2016.
  2. The option vests on the earlier of the one year anniversary of the grant date (10/27/17) or the date of Bio-Techne's 2017 annual meeting of shareholders.